Microneedle Drug Delivery CRO/CDMO
Hours: 8:30 AM–5:30 PMSales: +86 10 8928 7035Business: bd@casmn.com

ABOUT CASMN

Microneedle Development & Manufacturing Platform

CASMN integrates microneedle formulation development, process engineering, pilot scale-up and manufacturing capabilities across pharmaceutical, medical-device and skincare applications.

COMPANY PROFILE

About CASMN

Beijing CAS Microneedle Technology Co., Ltd., branded as CASMN, was founded in 2018 as a technology-commercialisation enterprise originating from the Technical Institute of Physics and Chemistry of the Chinese Academy of Sciences. The company focuses on polymer microneedle formulation development and industrialization across pharmaceutical, medical-device and functional-skincare programs.

CASMN operates a Beijing R&D and pilot platform with pilot-scale capacity of approximately 10 million patches per year, and a Chongqing scale-manufacturing base with an annual production capacity of approximately 150 million patches. The two bases support feasibility assessment, formulation and process development, analytical evaluation, pilot scale-up, clinical-stage sample preparation and manufacturing transition according to project requirements.

R&D AND MANUFACTURING FOOTPRINT

Two Bases, One Development Pathway

CASMN Beijing R&D and pilot platform building

Beijing R&D & Pilot Platform

Formulation and process development, analytical evaluation and pilot scale-up, supporting development verification and clinical-stage sample preparation. The platform has pilot-scale capacity of approximately 10 million patches per year.

CASMN Chongqing manufacturing environment

Chongqing Manufacturing Base

Chongqing has an annual production capacity of approximately 150 million patches for scale manufacturing. This figure does not describe pharmaceutical microneedle commercial-line capacity.

TECHNOLOGY & DEVELOPMENT PLATFORM

Integrated Microneedle Technology Platform

Dissolving microneedlesCoated microneedlesSwelling microneedlesFormulation developmentProcess developmentAnalytical evaluationPilot scale-upManufacturing transfer
Explore Technology →

SCIENTIFIC FOUNDATION

Research Supporting Development

20+Years of research foundation
50+Scientific publications
70+Patent applications

COMPANY MILESTONES

Company Milestones

2021

Chongqing Changshou base obtained a cosmetics production license

Cosmetics manufacturing base began operations

2022

Series A financing completed

Medical-device systems established at the Beijing Daxing base

Drug-development platform established

2023

Beijing Class II medical-device MAH milestone completed

Chongqing Class II medical-device approval obtained

2024

Beijing integrated R&D base entered operation

Postdoctoral research workstation established

View Full Company Timeline →

RESEARCH & INTELLECTUAL PROPERTY

Research & Intellectual Property

Peer-reviewed publications and patent activity provide scientific and intellectual-property foundations for the CASMN development platform.

Explore Research & IP →

Discuss a Microneedle Development Program

Start a Project